ARIAD PHARMACEUTICALS INC's ticker is and the CUSIP is 04033A950. A total of 2 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $566,000 | +53.4% | 76,600 | +32.8% | 0.00% | – |
| Q1 2016 | $369,000 | -15.4% | 57,700 | -17.3% | 0.00% | – |
| Q4 2015 | $436,000 | +0.5% | 69,800 | -6.2% | 0.00% | – |
| Q3 2015 | $434,000 | -62.4% | 74,400 | -46.7% | 0.00% | -100.0% |
| Q2 2015 | $1,155,000 | +51.8% | 139,700 | +51.4% | 0.00% | 0.0% |
| Q1 2015 | $761,000 | -11.9% | 92,300 | -26.6% | 0.00% | 0.0% |
| Q4 2014 | $864,000 | +92.9% | 125,700 | +51.4% | 0.00% | – |
| Q3 2014 | $448,000 | -24.3% | 83,000 | -10.8% | 0.00% | -100.0% |
| Q2 2014 | $592,000 | -39.2% | 93,000 | -22.9% | 0.00% | 0.0% |
| Q1 2014 | $973,000 | -62.8% | 120,700 | -68.5% | 0.00% | -66.7% |
| Q4 2013 | $2,615,000 | -33.0% | 383,400 | +80.8% | 0.00% | -50.0% |
| Q3 2013 | $3,903,000 | +86.6% | 212,100 | +77.3% | 0.01% | +50.0% |
| Q2 2013 | $2,092,000 | – | 119,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 1,327,800 | $9,122,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 2,311 | $1,588,000 | 0.05% |
| SIMPLEX TRADING, LLC | 74 | $18,000 | 0.00% |
| Citadel Advisors | 125,700 | $864,000 | 0.00% |